Annual Shareholders Equity
$4.99 M
-$2.48 M-33.22%
December 31, 2023
Summary
- As of February 7, 2025, PCSA annual stockholders equity is $4.99 million, with the most recent change of -$2.48 million (-33.22%) on December 31, 2023.
- During the last 3 years, PCSA annual shareholders equity has fallen by -$17.95 million (-78.25%).
- PCSA annual shareholders equity is now -80.42% below its all-time high of $25.49 million, reached on December 31, 2021.
Performance
PCSA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$3.72 M
-$2.30 M-38.23%
September 30, 2024
Summary
- As of February 7, 2025, PCSA quarterly stockholders equity is $3.72 million, with the most recent change of -$2.30 million (-38.23%) on September 30, 2024.
- Over the past year, PCSA quarterly shareholders equity has dropped by -$5.16 million (-58.12%).
- PCSA quarterly shareholders equity is now -88.13% below its all-time high of $31.34 million, reached on March 31, 2021.
Performance
PCSA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
PCSA Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.2% | -58.1% |
| 3 y3 years | -78.3% | -50.2% |
| 5 y5 years | -48.6% | -50.2% |
PCSA Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -80.4% | at low | -85.4% | at low |
| 5 y | 5-year | -80.4% | at low | -88.1% | at low |
| alltime | all time | -80.4% | +312.2% | -88.1% | +249.4% |
Processa Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.72 M(-38.2%) |
| Jun 2024 | - | $6.02 M(-32.2%) |
| Mar 2024 | - | $8.88 M(+78.1%) |
| Dec 2023 | $4.99 M(-33.2%) | $4.99 M(-30.4%) |
| Sep 2023 | - | $7.17 M(-21.7%) |
| Jun 2023 | - | $9.16 M(-9.7%) |
| Mar 2023 | - | $10.14 M(+35.8%) |
| Dec 2022 | $7.47 M(-70.7%) | $7.47 M(-56.7%) |
| Sep 2022 | - | $17.24 M(-14.2%) |
| Jun 2022 | - | $20.08 M(-13.6%) |
| Mar 2022 | - | $23.24 M(-8.8%) |
| Dec 2021 | $25.49 M(+11.1%) | $25.49 M(-6.3%) |
| Sep 2021 | - | $27.21 M(-7.0%) |
| Jun 2021 | - | $29.24 M(-6.7%) |
| Mar 2021 | - | $31.34 M(+36.6%) |
| Dec 2020 | $22.94 M(+186.3%) | $22.94 M(+315.0%) |
| Sep 2020 | - | $5.53 M(-16.2%) |
| Jun 2020 | - | $6.59 M(-8.9%) |
| Mar 2020 | - | $7.23 M(-9.7%) |
| Dec 2019 | $8.01 M(-17.4%) | $8.01 M(-7.6%) |
| Sep 2019 | - | $8.67 M(+2.0%) |
| Jun 2019 | - | $8.50 M(-6.8%) |
| Mar 2019 | - | $9.12 M(-6.0%) |
| Dec 2018 | $9.70 M | $9.70 M(-7.7%) |
| Sep 2018 | - | $10.51 M(-7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $11.31 M(+55.4%) |
| Mar 2018 | - | $7.28 M(+1849.7%) |
| Dec 2017 | $373.20 K(-115.9%) | $373.20 K(-1163.2%) |
| Sep 2017 | - | -$35.10 K(-98.6%) |
| Jun 2017 | - | -$2.49 M(+2.2%) |
| Mar 2017 | - | -$2.44 M(+3.7%) |
| Dec 2016 | -$2.35 M(+18.8%) | -$2.35 M(+4.5%) |
| Sep 2016 | - | -$2.25 M(+3.6%) |
| Jun 2016 | - | -$2.17 M(+2.5%) |
| Mar 2016 | - | -$2.12 M(+7.0%) |
| Dec 2015 | -$1.98 M(-263.8%) | -$1.98 M(+22.3%) |
| Sep 2015 | - | -$1.62 M(+22.5%) |
| Jun 2015 | - | -$1.32 M(-288.2%) |
| Mar 2015 | - | $701.80 K(-41.9%) |
| Dec 2014 | $1.21 M(-27.7%) | $1.21 M(-1134.2%) |
| Sep 2014 | - | -$116.80 K(-118.7%) |
| Jun 2014 | - | $623.00 K(-39.5%) |
| Mar 2014 | - | $1.03 M(-38.4%) |
| Dec 2013 | $1.67 M(-34.8%) | $1.67 M(-29.7%) |
| Sep 2013 | - | $2.38 M(+135.3%) |
| Jun 2013 | - | $1.01 M(-41.8%) |
| Mar 2013 | - | $1.74 M(-32.3%) |
| Dec 2012 | $2.56 M(-7.7%) | $2.56 M(-16.2%) |
| Sep 2012 | - | $3.06 M |
| Dec 2011 | $2.77 M | - |
FAQ
- What is Processa Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals annual shareholders equity year-on-year change?
- What is Processa Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Processa Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of PCSA is $4.99 M
What is the all time high annual shareholders equity for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high annual stockholders equity is $25.49 M
What is Processa Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, PCSA annual stockholders equity has changed by -$2.48 M (-33.22%)
What is Processa Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of PCSA is $3.72 M
What is the all time high quarterly shareholders equity for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high quarterly stockholders equity is $31.34 M
What is Processa Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, PCSA quarterly stockholders equity has changed by -$5.16 M (-58.12%)